Yong Wei

24PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Environmental biogeochemistryMolecular targetsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 26, 2026
The VCPIP1-UBE3A Deubiquitination-Ubiquitination Cascade Contributes to Castration-Resistant Prostate Cancer Progression.

|Oct 19, 2026
The NEK8/ALYREF axis promotes cisplatin resistance in bladder cancer by stabilizing CDK18 mRNA to facilitate DNA damage repair.

|Aug 27, 2026
Environmental Polyethylene Terephthalate Micro- and Nanoplastics Promote Clear Cell Renal Cell Carcinoma Progression Through Mitochondrial ROS-Associated AKT/GSK3β/β-Catenin Signaling.

|Jul 15, 2026
Tumor-Associated Macrophage Exosomal miR-142-5p Drives Prostate Cancer Neuroendocrine Differentiation via RERG/Ras/ERK Axis.

|Mar 20, 2026
A feedback mechanism from prostate cancer cells to macrophages, reinforced by STAT1, regulates tumor progression and resistance to radiotherapy.

Jia-Yin Chen, Yu-Ting Xue, Bin Lin

|Dec 02, 2025
Super-enhancers mediates SLC7A11 via FOXA1 to regulate disulfidptosis in prostate cancer.

Zhen Kang, Bin Lin, Zhi-Bin Ke

Pageof 4

Frequent Collaborators

21 joint publications

Ning Xu

20 joint publications

Xueyi Xue

7 joint publications

Qingshui Zheng

5 joint publications

Zhi-Bin Ke